Trial Profile

A Phase 1 Dose-ranging Study of GH001 in Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 25 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 5 Methoxy N N Dimethyltryptamine (Primary)
Indications Depression; Major depressive disorder
Focus Adverse reactions
Sponsors GH Research

Most Recent Events

15 May 2025 According to a GH Research media release, company announces acceptance of poster has been accepted presenting data at the American Society of Clinical Psychopharmacology Annual Meeting (ASCP) in Arizona, United States from May 27 - 30.
18 Oct 2022 Results assessing the safety, tolerability, and the dose-related psychoactive effects of GH001 in healthy volunteers presented at the 35th Annual Congress of the European College of Neuropsychopharmacology
30 Nov 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com